Lividomycin is a broad-spectrum aminoglycoside antibiotic.[1] It is effective against most Gram-positive and Gram-negative bacteria including Mycobacterium tuberculosis (the causative agent of tuberculosis) and Pseudomonas aeruginosa.[2]

References

  1. ^ Kobayashi F, Yamaguchi M, Mitsuhashi S (January 1972). "Activity of lividomycin against Pseudomonas aeruginosa: its inactivation by phosphorylation induced by resistant strains". Antimicrobial Agents and Chemotherapy. 1 (1): 17–21. doi:10.1128/AAC.1.1.17. PMC 444159. PMID 4207755.
  2. ^ Kobayashi F, Nagoya T, Yoshimura Y, Kaneko K, Ogata SI (February 1972). "Studies on New Antibiotic Lividomycins. V In vitro and in vivo antimicrobial activity of lividomycin A". The Journal of Antibiotics. 25 (2): 128–136. doi:10.7164/antibiotics.25.128. PMID 4624613.
Allikas: https://en.wikipedia.org/wiki/Lividomycin
No tags for this post.